Get started
Author

Xuanfu Xu

Observed name: Xu, Xuanfu
ORCID: 0000-0002-4506-7220
Observed ORCID: 0000-0002-4506-7220
OpenAlex ID: A5037006855
Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c‐myc/hexokinase 2 pathway
2022 · Qiang Yu, Weiqi Dai, et al. · Journal of Cellular and Molecular Medicine · 56
Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4‐xCT pathway
2024 · Jie Ji, Ziqi Cheng, et al. · Journal of Cellular and Molecular Medicine · 37
TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system
2024 · Jie Zhang, Malire Yimamu, et al. · Free Radical Biology and Medicine · 21
Hepatocyte‐derived exosomes deliver the lncRNA CYTOR to hepatic stellate cells and promote liver fibrosis
2024 · Wenqiang Xu, Wenhui Mo, et al. · Journal of Cellular and Molecular Medicine · 15
PDF
Silencing of OGDHL promotes liver cancer metastasis by enhancing hypoxia inducible factor 1 α protein stability
2022 · Weiqi Dai, Yueyue Li, et al. · Cancer Science · 15
Systematic analysis of glutamine metabolism family genes and exploration of the biological role of GPT in colorectal cancer
2023 · Weiqi Dai, Wenhui Mo, et al. · Aging · 7
PDF
Colonoscopy Combined with Me-Nbi to Observe the Canceration Characteristics of Colon Polyps and the Correlation of RHOC Protein Expression
2023 · Shuqi Xu, Weimin Chen, et al. · Cellular and Molecular Biology
PDF
Works count: 9
Citation count: 165
H-index: 7
I10-index: 6
Year
Topic
Type